Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMRT alone vs CCRT in low-risk locally advanced nasopharyngeal carcinoma
NCT01817023Phase 3Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Apr 2013
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin in nasopharyngeal carcinoma (NPC), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
cisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01817023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01817023.